Reverse cardio-oncology: neuroendocrine axis activation and cardiovascular-disease-derived factors synergistically remodel the tumor microenvironment

Cardiovascular disease and cancer are increasingly recognized as biologically interconnected conditions with a bidirectional relationship. In addition to the well-established cardiotoxic effects of cancer therapies, accumulating epidemiological and experimental evidence suggests that cardiovascular disease may influence cancer initiation, progression, and metastasis, a concept referred to as reverse cardio-oncology. However, the mechanisms linking cardiovascular pathology to tumor microenvironment remodeling remain incompletely defined and are likely to involve multiple interacting systemic and local pathways. In this review, we summarize current evidence regarding the potential contribution of cardiovascular stress, neuroendocrine activation, metabolic dysregulation, impaired oxygen delivery, physical inactivity, and cardiovascular disease-derived secretory factors to tumor microenvironment remodeling. Particular attention is given to vascular endothelial growth factor, extracellular vesicles, reactive oxygen species, and inflammatory cytokines, which may act as interconnected mediators of angiogenesis, immune suppression, oxidative stress, and metastatic progression. We further discuss how these pathways may converge within a broader hierarchical and network-based framework, while emphasizing that much of the current mechanistic evidence remains derived from observational studies, animal models, and in vitro systems. Finally, we highlight therapeutic implications, including modulation of neuroendocrine and inflammatory signaling, and propose future directions involving human tissues, clinical samples, and heart-cancer-on-a-chip platforms. Overall, this review aims to provide a balanced synthesis of current knowledge and unresolved questions in reverse cardio-oncology, with the goal of supporting more integrated investigation of cardiovascular disease-cancer interactions.

Authors

Institutions

Publication Details

Journal
Cellular Oncology
Published
2026-06-28
DOI
https://doi.org/10.1007/s13402-026-01243-0
Primary Topic
Cancer, Stress, Anesthesia, and Immune Response
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reverse cardio-oncology: neuroendocrine axis activation and cardiovascular-disease-derived factors synergistically remodel the tumor microenvironment

Xin Hu, Siyu Ji, Nan Zhang
Cellular Oncology
Cancer, Stress, Anesthesia, and Immune Response
article

Reverse cardio-oncology: neuroendocrine axis activation and cardiovascular-disease-derived factors synergistically remodel the tumor microenvironment

Xin Hu, Siyu Ji, Nan Zhang
article en

Abstract

Cardiovascular disease and cancer are increasingly recognized as biologically interconnected conditions with a bidirectional relationship. In addition to the well-established cardiotoxic effects of cancer therapies, accumulating epidemiological and experimental evidence suggests that cardiovascular disease may influence cancer initiation, progression, and metastasis, a concept referred to as reverse cardio-oncology. However, the mechanisms linking cardiovascular pathology to tumor microenvironment remodeling remain incompletely defined and are likely to involve multiple interacting systemic and local pathways. In this review, we summarize current evidence regarding the potential contribution of cardiovascular stress, neuroendocrine activation, metabolic dysregulation, impaired oxygen delivery, physical inactivity, and cardiovascular disease-derived secretory factors to tumor microenvironment remodeling. Particular attention is given to vascular endothelial growth factor, extracellular vesicles, reactive oxygen species, and inflammatory cytokines, which may act as interconnected mediators of angiogenesis, immune suppression, oxidative stress, and metastatic progression. We further discuss how these pathways may converge within a broader hierarchical and network-based framework, while emphasizing that much of the current mechanistic evidence remains derived from observational studies, animal models, and in vitro systems. Finally, we highlight therapeutic implications, including modulation of neuroendocrine and inflammatory signaling, and propose future directions involving human tissues, clinical samples, and heart-cancer-on-a-chip platforms. Overall, this review aims to provide a balanced synthesis of current knowledge and unresolved questions in reverse cardio-oncology, with the goal of supporting more integrated investigation of cardiovascular disease-cancer interactions.

Cellular Oncology
Union Hospital (HK), Jilin University (CN), Union Hospital (CN)
Good health and well-being
Openalex Percentile: Top 7%
Cancer, Stress, Anesthesia, and Immune Response
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.